Patents by Inventor Patrick R. Connelly

Patrick R. Connelly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020133208
    Abstract: An electromagnetic immune tissue invasive system includes a primary device housing. The primary device housing having a control circuit therein. A shielding is formed around the primary device housing to shield the primary device housing and any circuits therein from electromagnetic interference. A lead system transmits and receives signals between the primary device housing. The lead system is either a fiber optic system or an electrically shielded electrical lead system.
    Type: Application
    Filed: February 19, 2002
    Publication date: September 19, 2002
    Inventor: Patrick R. Connelly
  • Publication number: 20020128691
    Abstract: An electromagnetic immune tissue invasive system includes a primary device housing. The primary device housing having a control circuit therein. A shielding is formed around the primary device housing to shield the primary device housing and any circuits therein from electromagnetic interference. A lead system transmits and receives signals between the primary device housing. The lead system is either a fiber optic system or an electrically shielded electrical lead system.
    Type: Application
    Filed: February 19, 2002
    Publication date: September 12, 2002
    Inventor: Patrick R. Connelly
  • Publication number: 20020128689
    Abstract: An electromagnetic immune tissue invasive system includes a primary device housing. The primary device housing having a control circuit therein. A shielding is formed around the primary device housing to shield the primary device housing and any circuits therein from electromagnetic interference. A lead system transmits and receives signals between the primary device housing. The lead system is either a fiber optic system or an electrically shielded electrical lead system.
    Type: Application
    Filed: February 19, 2002
    Publication date: September 12, 2002
    Inventors: Patrick R. Connelly, Stuart G. MacDonald
  • Publication number: 20020038135
    Abstract: An implantable device used to monitor and maintain at least one physiologic function, which is capable of operating in the presence of damaging electromagnetic interference. The implantable device includes primary and secondary modules, each independently protected from EMI damage via at least one shielding and/or filtering, and a non-electrical communication device for communicating in at least one direction between the primary and the secondary modules. The primary module, in response to input from electrical sensing leads, activates the secondary module in a failsafe mode. In the failsafe mode, the secondary module carries out a physiologic function upon activation and in the presence of electromagnetic interference.
    Type: Application
    Filed: April 20, 2001
    Publication date: March 28, 2002
    Inventors: Patrick R. Connelly, Michael Weiner, Wilson Greatbatch
  • Patent number: 5255976
    Abstract: A temperature gradient calorimeter and method of calculating heats of reactions is disclosed. The calorimeter has a two dimensional array of reaction chambers located in a thermally conductive substrate. A first heat transfer medium is in thermal contact with the thermal conductive substrate and is located at one region of the array of reaction chambers. A second heat transfer medium is in thermal contact with the thermal conductive substrate and is located on the opposite side of the array from the first heat transfer medium. The first and second heat transfer mediums are at two different temperatures. That temperature difference produces a temperature gradient across the array of reaction chambers.The fluorescence intensities are measured for reactant samples located in the array of reaction chambers.
    Type: Grant
    Filed: July 10, 1992
    Date of Patent: October 26, 1993
    Assignee: Vertex Pharmaceuticals Incorporated
    Inventor: Patrick R. Connelly